These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 433601)
1. Activated complement in the sputum from patients with cystic fibrosis. Schiøtz PO; Sørensen H; Høiby M Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601 [TBL] [Abstract][Full Text] [Related]
2. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis. Schiøtz PO; Høiby N; Permin H; Wiik A Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in serum and sputum from patients with cystic fibrosis. Schiøtz PO; Egeskjold EM; Høiby N; Permin H Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
5. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection. Schiøtz PO; Nielsen H; Høiby N; Glikmann G; Svehag SE Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):37-40. PubMed ID: 707104 [TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases. Holby N; Olling S Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841 [TBL] [Abstract][Full Text] [Related]
7. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum. Schiller NL; Millard RL Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945 [TBL] [Abstract][Full Text] [Related]
9. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. Meluleni GJ; Grout M; Evans DJ; Pier GB J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254 [TBL] [Abstract][Full Text] [Related]
10. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. Jensen PØ; Moser C; Kharazmi A; Presler T; Koch C; Høiby N J Cyst Fibros; 2006 Aug; 5(3):145-51. PubMed ID: 16503423 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607 [TBL] [Abstract][Full Text] [Related]
12. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828 [TBL] [Abstract][Full Text] [Related]